Alteration of Glial Fibrillary Acidic Proteins Immunoreactivity in Astrocytes of the Spinal Cord Diabetic Rats

Abstract

Diabetes affects retinal and nervous glial cells, especially the astrocytes. A key indicator of this response is the alteration in the level of intermediate filament glial fibrillary acidic protein (GFAP) and number of GFAP-immunoreactive astrocytes. To date, no study has investigated the effect of diabetes on the distribution of GFAP-immunoreactive astrocytes in the spinal cord. Therefore, the present study investigated the effect of diabetes on the number of GFAP-immunoreactive astrocytes in the gray matter of the spinal cord of streptozotocin-induced diabetic Wistar rats. Animals were divided into six groups (n 5 7); 6 weeks and 12 weeks diabetic duration groups and their respective age-matched normal control and sham control groups. Our results demonstrated a significant (P < 0.001) decrease in the number of GFAP-immunoreactive astrocytes in different areas of the spinal cord sections of the 6 weeks and 12 weeks long diabetic rats when compared with the spinal cord of normal and sham control groups of comparable age. The mean percentage in total number of GFAP-immunoreactive astrocytes in the whole gray matter areas of the spinal cord of the 6 and 12 weeks diabetic groups were approximately 28% and 41% less than control groups. Furthermore, the 12 weeks diabetic group showed a significant (P < 0.001) reduction in the number of GFAP-immunoreactive astrocytes when compared with the 6 weeks diabetic animals. These results suggest that the induction of diabetes is associated with a reduction in GFAP-positive astrocytes in the spinal cord, which may affect the functional support and role of astrocytic cells in the nervous tissue. This in turn may contribute to the pathological changes associated with diabetic state in the central nervous system. Anat

Decreased astrocytic GFAP expression in streptozotocin-induced diabetes after gliotoxic lesion in the rat brainstem

“…Meanwhile, decreased astrocyte GFAP expression in type 1 diabetic rats was also found by other researchers with no additional harmful condition beyond diabetes (11,(18)(19)(20)(21)(22). On the other hand, insulin treatment has shown to prevent diabetes-induced decreases in astrocytic GFAP content (11) Although astrocytes were not individually counted in our study, the decrease in GFAP content seen in diabetic rats apparently reflected a decrease in GFAP expression rather than a decrease in the number of astrocytes.…”

(-)-Epigallocatechin-3-Gallate Modulates Spinal Cord Neuronal Degeneration by Enhancing Growth-Associated Protein 43, B-Cell Lymphoma 2, and Decreasing B-Cell Lymphoma 2-Associated X Protein Expression after Sciatic Nerve Crush Injury

“…[28][29][30] Briefly, every 15th transverse section of lumbar spinal cord (a total of 10 sections per spinal cord; n = 6 in all groups) was selected for free floating immunostaining in a 24-well culture plate. In control spinal cord, regions of the spinal cord identical to that in the sciatic nerve-lesioned animal were selected for staining.…”

Alteration of Dentate Gyrus Astrocytes in Diabetic Rats: Protective Role of Urtica dioica

“…Astrocytes have effective roles in supporting of neurons, scar formation and maintenance of the blood-brain barrier (Afsari et al, 2008), vascular reactivity, regulation of extracellular glutamate levels, energy metabolism, and protection from reactive oxygen species in the central nervous system (Dringen et al, 2000;Tsacopoulos & Magistretti, 1996;Zonta et al, 2003).…”